Comparison of brain activity between dopamine D2 receptor-knockout and wild mice in response to dopamine agonist and antagonist assessed by fMRI

NeuroSignals

Volumn 13, Issue 5, 2004, Pages 227-240

  Kuriwaki, Jun Ichi ^a   Nishijo, Hisao ^a,b   Kondoh, Takashi ^c   Uwano, Teruko ^a   Torii, Kunio ^c   Katsuki, Motoya ^d   Ono, Taketoshi ^a,b  

^a UNIVERSITY OF TOYAMA   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c AJINOMOTO CO INC   (Japan)

^d NATIONAL INSTITUTE FOR BASIC BIOLOGY   (Japan)

Author keywords

Amygdala; Antipsychotic drugs; Bromocriptine; Caudate putamen; Functional MRI; Hippocampal formation; Spiperone

Indexed keywords

BROMOCRIPTINE; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; SPIPERONE;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CAUDATE NUCLEUS; CINGULATE GYRUS; CONTROLLED STUDY; ELECTROENCEPHALOGRAM; HIPPOCAMPUS; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEUS ACCUMBENS; PUTAMEN; SIGNAL TRANSDUCTION; SOMATOSENSORY CORTEX; THALAMUS; WILD TYPE;

ANIMALS; BRAIN; BRAIN MAPPING; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; MAGNETIC RESONANCE IMAGING; MALE; MICE; MICE, KNOCKOUT; OXYGEN; RECEPTORS, DOPAMINE D2; TIME FACTORS;

EID: 4344586213     PISSN: 1424862X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000079337     Document Type: Article

References (43)

1. Vallone D, Picetti R, Borrelli E: Structure and function of dopamine receptors. Neurosci Biobehav Rev 2000;24:125-132.
2. Jaber M, Robinson SW, Missale C, Caron MG: Dopamine receptors and brain function. Neuropharmacology 1996;35:1503-1519.
3. Missale C, Nash SR, Robinson SW, Jaber M, Caron MG: Dopamine receptors: From structure to function. Physiol Rev 1998;78:189-225.
4. McCulloch J, Savaki HE, Sokoloff L: Distribution of effects of haloperidol on energy metabolism in the rat brain. Brain Res 1982;243:81-90.
5. Pizzolato G, Soncrant TT, Larson DM, Rapoport SI: Reduced metabolic response of the rat brain to haloperidol after chronic treatment. Brain Res 1985;337:1-9.
6. Pizzolato G, Soncrant TT, Rapoport SI: Haloperidol and cerebral metabolism in conscious rat: Relation to pharmacokinetics. J Neurochem 1984;43:724-732.
7. Wamsley JK, Gehlert DR, Filloux FM, Dawson TM: Comparison of the distribution of D1 and D2 dopamine receptors in the rat brain. J Chem Neuroanat 1989;2:119-137.
8. Jackson DM, Westlind-Danielsson A: Dopamine receptors: Molecular biology, biochemistry and behavioural aspects. Pharmacol Ther 1994;64:291-369.
9. Pizzolato G, Soncrant TT, Rapoport SI: Time-course and regional distribution of the metabolic effects of bromocriptine in the rat brain. Brain Res 1985;341:303-312.
10. Seeman P, Van Tol HHM: Dopamine receptor pharmacology. Trends Pharmacol Sci 1994;15:264-270.
11. Kelly MA, Rubinstein M, Phillips TJ, Lessov CN, Burkhart-Kasch S, Zhang G, Bunzow JR, Fang Y, Gerhardt GA, Grandy DK, Low MJ: Locomotor activity in D2 dopamine receptordeficient mice is determined by gene dosage, genetic background, and developmental adaptations. J Neurosci 1998;18:3470-3479.
12. Yamaguchi H, Aiba A, Nakamura K, Nakao K, Sakagami H, Goto K, Kondo H, Katsuki M: Dopamine D2 receptor plays a critical role in cell proliferation and proopiomelanocortin expression in the pituitary. Genes Cells 1996;1:253-268.
13. Ogawa S, Lee TM, Kay AR, Tank DW: Brain magnetic resonance imaging with contrast dependent on blood oxygenation. Proc Natl Acad Sci USA 1990;87:9868-9872.
14. Ogawa S, Menon RS, Tank DW, Kim SG, Merkle H, Ellermann JM, Ugurbil K: Functional brain mapping by blood oxygenation leveldependent contrast magnetic resonance imaging. A comparison of signal characteristics with a biophysical model. Biophys J 1993;64:803-812.
15. Preece M, Mukherjee B, Huang CLH, Hall LD, Leslie RA, James MF: Detection of pharmacologically mediated changes in cerebral activity by functional magnetic resonance imaging: The effects of sulpiride in the brain of the anaesthetized rat. Brain Res 2001;916:107-114.
16. Hagino H, Tabuchi E, Kurachi M, Saitoh O, Sun Y, Kondoh T, Ono T, Torii K: Effects of D2 dopamine receptor agonist and antagonist on brain activity in the rat assessed by functional magnetic resonance imaging. Brain Res 1988:813:367-373.
17. Li R, Wing LL, Kirch DG, Wyatt RJ, Chuang DM: Effects of chronic nicotine and haloperidol administration on muscarinic receptor-mediated phosphoinositide turnover in rat brain slices. Psychopharmacology 1992;109:248-250.
18. Holtom PE, Needham PL, Bennett GW, Aspley S: Chronic, but not acute, dosing of antipsychotic drugs alters neurotensin binding in rat brain regions. Br J Pharmacol 2000;131:990-996.
19. 1-adrenergic receptor in rat cerebral frontal cortex. Cell Signal 1999;11:293-300.
20. Van den Buuse M, Lambrechts AC: Bromocriptine-induced decrease in blood pressure in conscious spontaneously hypertensive rats: Evidence for a peripheral site of action. J Pharm Phermacol 1989;41:644-646.
21. Bradley WG: Flow phenomena; in Magnetic Resonance Imaging. St Louis, Mosby, 1988, pp 359-374.
22. Detre J, Leigh JS, Williams DS, Koretsky P: Perfusion imaging. Magn Res Med 1992;23:37-45.
23. Ogawa S, Tank DW, Menon R, Ellermann JM, Kim SG, Merkle H, Ugurbil K: Intrinsic signal changes accompanying sensory stimulation: Functional brain mapping with magnetic resonance imaging. Proc Natl Acad Sci USA 1992;89:5951-5955.
24. Hof PR, Young WG, Bloom FE, Belichenko PV, Celio MR: Comparative Cytoarchitectonic Atlas of the C57BL/6 and 129/Sv Mouse Brains. Amsterdam, Elsevier, 2000.
25. Tran AH, Tamura R, Uwano T, Kobayashi T, Katsuki M, Matsumoto G, Ono T: Altered accumbens neural response to prediction of reward associated with place in dopamine D2 receptor knockout mice. Proc Natl Acad Sci USA 2002;99:8986-8991.
26. West MO: Anesthetics eliminate somatosensory-evoked discharges of neurons in the somatotopically organized sensorimotor striatum of the rat. J Neurosci 1998;18:9055-9068.
27. Chapman CD, Gazzara RA, Howard SG: Effects of phencyclidine on extracellular levels of dopamine, dihydroxyphenylacetic acid and homovanillic acid in conscious and anesthetized rats. Neuropharmacology 1990;29:319-325.
28. Hu XT, Wachtel SR, Galloway MP, White FJ: Lesions of the nigrostriatal dopamine projection increase the inhibitory effects of D1 and D2 dopamine agonists on caudate-putamen neurons and relative D2 receptors from the necessity of D1 receptor stimulation. J Neurosci 1990;10:2318-2329.
29. Piercey MF, Hyslop DK, Hoffman WE: Excitation of type II caudate neurons by systemic administration of dopamine agonists. Brain Res 1996;706:249-258.
30. Shi WX, Smith PL, Pun CLP, Millet B, Bunney BS: D1-D2 interaction in feedback control of midbrain dopamine neurons. J Neurosci 1997;17:7988-7994.
31. Warenycia MW, McKenzie GM: Excitation of striatal neurons by dexamhetamine is not abolished by either chloral hydrate or urethane anaesthesia. Neuropharmacology 1988;27:1309-1312.
32. Groenewegen HJ, Wright CI, Beijer AV, Voorn P: Convergence and segregation of ventral striatal inputs and outputs. Ann NY Acad Sci 1999;877:49-63.
33. Chiara GD: Nucleus accumbens shell and core dopamine: Differential role in behavior and addiction. Behav Brain Res 2002;137:75-114.
34. Heimer L, Alheid GF, de Olmos JS, Groenewegen HJ, Haber SN, Harlan RE, Zahm DS: The accumbens: Beyond the core-shell dichotomy. J Neuropsychiat Clin Neurosci 1997;9:354-381.
35. Marinelli M, Piazza PV: Interaction between glucocorticoid hormones, stress and psychostimulant drugs. Eur J Neurosci 2002;16:387-394.
36. Rebec GV: Real-time assessments of dopamine function during behavior: Single-unit recording, iontophoresis, and fast-scan cyclic voltammetry in awake, unrestrained rats. Alcohol Clin Exp Res 1998;22:32-40.
37. Otmakhova NA, Lisman JE: Dopamine selectively inhibits the direct cortical pathway to the CA1 hippocampal region. J Neurosci 1999;19:1437-1445.
38. Yang CR, Mogenson GJ: Hippocampal signal transmission to the pedunculopontine nucleus and its regulation by dopamine D2 receptors in the nucleus accumbens: An electrophysiological and behavioural study. Neuroscience 1987;23:1041-1055.
39. Wilkerson A, Levin ED: Ventral hippocampal dopamine D1 and D2 systems and spatial working memory in rats. Neuroscience 1999;89:743-749.
40. Carlsson A: The current status of the dopamine hypothesis of schizophrenia. Neuropsychopharmacology 1988;1:179-186.
41. Carlsson M, Carlsson A: Interactions between glutamatergic and monoaminergic systems within the basal ganglia - Implications for schizophrenia and Parkinson's disease. Trends Neurosci 1990;13:272-276.
42. Shenton ME, Dickey CC, Frumin M, McCarley RW: A review of MRI findings in schizophrenia. Schizophr Res 2001;49:1-52.
43. Stahl SM: Essential Psychopharmacology: Neuroscientific Basis and Practical Applications, ed 2. Cambridge, Cambridge University Press, 2000.